11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine
Key Takeaways
- Federal emergency oral Schedule II rules allow limited emergency dispensing with a covering prescription within 7 days; quantity must be limited to the emergency period, and Illinois practice layers corresponding responsibility and e-prescribing realities.
- 225 ILCS 85 §15.3 authorizes pharmacist emergency supply of noncontrolled chronic medications when refill authorization cannot be obtained, prior therapy exists at the pharmacy, interruption risks harm, patient is notified, and the prescriber is informed—total supply not exceeding 30 days.
- OTC drugs are available without a prescription; BTC products (notably pseudoephedrine under CMEA) sit behind the counter with ID, logbook, and quantity limits even though they are not full legend prescriptions.
- CMEA pseudoephedrine limits: 3.6 g/day and 9 g per 30 days retail (7.5 g per 30 days mail-order), with purchaser photo ID and logbook (or electronic equivalent) requirements.
- Do not dispense adulterated, expired, recalled, or otherwise unfit drug products; conditions prohibiting dispensing override convenience and emergency-supply desires.
11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine
Quick Answer: Emergency oral Schedule II dispensing follows federal limits (quantity for the emergency only; covering prescription within 7 days). Illinois 225 ILCS 85 §15.3 separately allows a pharmacist to dispense an emergency supply of noncontrolled chronic medication when refill authorization cannot be obtained, prior fills exist, interruption risks harm, the patient is notified, and the prescriber is informed—not more than a 30-day supply. Pseudoephedrine is behind-the-counter under CMEA with 3.6 g/day and 9 g/30-day retail limits (mail-order 7.5 g/30 days), photo ID, and logbook. Never dispense expired, adulterated, or recalled stock.
This section closes NABP Area 3 themes on exceptions to ordinary dispensing/refilling, OTC/BTC, and conditions prohibiting dispensing.
Emergency Oral Schedule II (Federal Core + Illinois Overlay)
When emergency oral CII is allowed
Federal controlled-substance rules permit an oral Schedule II prescription only in a true emergency: immediate administration is necessary, no appropriate alternative is available, and it is not reasonably possible for the prescriber to provide a written/electronic prescription at that moment. Key limits:
| Requirement | Federal expectation |
|---|---|
| Quantity | Limited to the amount adequate to treat the patient during the emergency period |
| Pharmacist duty | Reduce the oral order to writing immediately with all required elements |
| Covering prescription | Prescriber must deliver a signed written/electronic covering prescription within 7 days |
| If covering Rx fails | Pharmacist must report to the DEA (classic federal follow-up duty) |
| “Emergency” for convenience | Not valid—clinic closed for the weekend without a true emergency is a common trap |
Illinois practice still expects corresponding responsibility, legitimacy analysis, and compliance with Illinois CS/e-prescribing frameworks. An emergency oral CII is not a loophole to ignore red flags. If the covering prescription does not arrive, treat that as a regulatory failure pathway, not a paperwork inconvenience.
Partial fills and other CII “exceptions” (context only)
Emergency oral CII is one exception family. Other CII flexibilities (partial fills under federal partial-fill rules, LTCF/hospice pathways) are not unlimited refills and do not convert CII into CIII. When a stem mixes emergency oral CII with “give three months and five refills,” every refill authorization is still illegal.
Illinois Emergency Refills of Noncontrolled Drugs: 225 ILCS 85 §15.3
Illinois enacted a clear statutory emergency-refill pathway for chronic medications when the prescriber cannot be reached for refill authorization.
Mandatory conditions (all must fit)
A pharmacist may exercise professional judgment to dispense an emergency supply for a chronic disease or condition if unable to obtain refill authorization when:
- In the pharmacist’s professional judgment, interruption of therapy might reasonably produce undesirable consequences or patient suffering
- The pharmacy previously dispensed or refilled a prescription from the prescriber for the same patient and medication
- The prescription is not for a controlled substance
- The pharmacist informs the patient/agent that prescriber authorization is required for future refills (verbal, electronic, or written notice)
- The emergency dispensing is documented in the patient’s prescription record and the pharmacist informs the prescriber of the emergency refill
Quantity limit
The emergency supply is limited to the amount needed for the emergency period in the pharmacist’s judgment, but the total amount dispensed shall not exceed a 30-day supply.
| Allowed under §15.3 | Not allowed under §15.3 |
|---|---|
| Noncontrolled chronic therapy with prior history at the pharmacy | Any controlled substance emergency refill under this section |
| Up to 30-day maximum supply | First-time fill of a drug never dispensed for that patient at the pharmacy |
| Documented notice to patient + prescriber | Silent “just this once” without documentation |
| Professional judgment that interruption would harm | Lifestyle convenience without clinical risk of interruption |
Exam discipline: If the drug is alprazolam, oxycodone, or any CS, §15.3 does not authorize the emergency refill. Use only lawful CS pathways (new Rx, remaining authorized refills, true emergency oral CII rules when applicable)—do not misapply the non-CS statute.
Professional judgment framing
Section 15.3 is not a blank check. It is a structured exception: prior relationship with the drug at that pharmacy, chronic therapy, non-CS only, hard 30-day cap, and dual communication (patient + prescriber). When facts are uncertain, default to attempting authorization and documenting failed contacts before invoking the emergency supply.
OTC vs BTC vs Prescription
| Category | Prescription required? | Access control |
|---|---|---|
| OTC (over-the-counter) | No | Front-store retail sale; Drug Facts labeling |
| BTC (behind the counter) | No prescription, but restricted sale | Staff-controlled access, ID/log/quantity rules (PSE) |
| Prescription (Rx / legend) | Yes (or other lawful order) | Valid Rx + pharmacist dispensing |
The Durham-Humphrey Amendment established the federal prescription vs OTC distinction. BTC is a later public-safety hybrid—most famously for pseudoephedrine under the Combat Methamphetamine Epidemic Act (CMEA).
Pseudoephedrine / CMEA Rules (High Yield Numbers)
Retail sellers of scheduled listed chemical products containing pseudoephedrine, ephedrine, or phenylpropanolamine must comply with CMEA controls:
| Control | Standard exam number/rule |
|---|---|
| Daily limit | 3.6 grams of base per purchaser per day |
| 30-day retail limit | 9 grams per purchaser per 30 days |
| 30-day mail-order limit | 7.5 grams per purchaser per 30 days |
| Placement | Behind the counter or in a locked cabinet |
| ID | Government-issued photo identification |
| Logbook | Written or electronic log with product, quantity, purchaser name/address, date/time, signature (retain per federal retention rules—classically 2 years) |
| Training | Seller training/self-certification obligations for regulated sellers |
Practical math check: A 30 mg pseudoephedrine HCl tablet is not 30 mg of pure base; exam items sometimes give package sizes and expect you to know the gram caps, not to invent pharmacy-specific Illinois numbers beyond CMEA. If a state imposes stricter local rules, follow the stricter rule—but the Illinois MPJE bank repeatedly drills the federal CMEA numbers.
BTC sale process (memory flow)
- Confirm product is PSE/regulated listed chemical product
- Check quantity against 3.6 g day / 9 g 30-day retail caps
- Require photo ID
- Complete logbook entry (or electronic equivalent)
- Complete sale only if limits and documentation succeed
- Refuse when the purchaser exceeds limits or refuses ID/log requirements
Conditions Prohibiting Dispensing
Even with a perfect prescription or an anxious patient, do not dispense products that are unfit for use. Core prohibitions:
| Condition | Why dispensing is unlawful/unsafe |
|---|---|
| Expired stock (manufacturer expiration or pharmacy BUD passed) | Potency/safety no longer assured |
| Adulterated drug (filth, contamination, improper storage, cGMP failures, compromised integrity) | FD&C Act adulteration concepts |
| Misbranded product (false/missing required labeling) | FD&C Act misbranding concepts |
| Recalled lots (especially Class I) | Known defect/risk |
| Illegitimate prescription (forged, out-of-scope, not for legitimate medical purpose) | Corresponding responsibility / Illinois good faith |
| CS without required credentials/elements | Federal + Illinois CS rules |
Adulteration vs misbranding quick reset:
- Adulteration focuses on the product’s quality/composition/manufacture/storage (e.g., not made under cGMP; contaminated; strength differs from professed)
- Misbranding focuses on labeling/representation (false claims, missing required information)
A recalled bottle that is also past expiration may be both unfit and a professional-judgment stop. Emergency-supply authority never revives expired inventory.
Integrating the Exceptions Without Breaking the System
Decision tree for the MPJE:
- Is there a valid current prescription with remaining authorized fills? → Dispense normally.
- Is it a true emergency oral CII? → Federal emergency pathway + covering Rx in 7 days.
- Is it a non-CS chronic therapy with prior pharmacy history and unreachable prescriber? → Evaluate §15.3 (≤30 days, document, notify).
- Is the patient seeking PSE? → CMEA BTC rules, not a prescription model.
- Is the stock expired/recalled/adulterated? → Stop. Source usable product or decline.
Exam Scenarios
Scenario A. Patient on chronic metformin, no refills, PCP office closed holiday weekend, pharmacy has prior fill history, interruption risks hyperglycemia. Pharmacist documents, notifies patient about future authorization need, informs prescriber, dispenses ≤30-day emergency supply under §15.3.
Scenario B. Same facts but drug is alprazolam. §15.3 does not apply (controlled substance).
Scenario C. ER physician phones true emergency oral CII for acute trauma pain with no ability to send EPCS immediately. Pharmacist reduces to writing, limits quantity to emergency period, expects covering Rx within 7 days.
Scenario D. Customer wants three large PSE boxes exceeding 3.6 g base in one day. Sale must be refused/limited to lawful gram caps with ID/log compliance.
Scenario E. Only stock of a chronic non-CS drug is expired. Emergency authority does not authorize dispensing expired product.
Common Traps
- Using §15.3 for controlled substances
- Exceeding the 30-day emergency non-CS cap
- Skipping documentation or prescriber notice on emergency supply
- Treating oral CII as routine convenience when no true emergency exists
- Forgetting CMEA 3.6 / 9 / 7.5 gram structure or mail-order difference
- Dispensing recalled or expired drugs “because the patient needs something today”
Master emergency CII, Illinois §15.3 non-CS emergency supply, OTC vs BTC, CMEA math, and hard stops for unfit products. Together with transfers, labels, and substitution, you now own the core of Area 3 dispensing requirements product-release decisions.
Under 225 ILCS 85 §15.3, which requirement must be true for an Illinois pharmacist’s emergency supply of chronic medication?
What is the federal retail 30-day purchase limit for pseudoephedrine base under the Combat Methamphetamine Epidemic Act (non-mail-order)?
Which statement correctly describes federal emergency oral Schedule II prescribing/dispensing limits commonly tested with Illinois practice?
A pharmacist is asked to provide an emergency supply, but the only remaining bottles of the noncontrolled chronic medication are past their expiration date. What is the correct action?